Why the study?
Do newer antihypertensive drugs with favorable metabolic and hemodynamic effects reduce coronary heart disease mortality in patients with hypertension compared to standard therapy?
Population
Patients with hypertension
Comparison
Newer antihypertensive drugs with favorable… vs Previously employed antihypertensive therapy…
Design
Review
Authors
Loading...
Theoretical support for newer antihypertensives does not justify practice change; leaves open whether they reduce CHD beyond BP lowering.
Do newer antihypertensive drugs with favorable metabolic and hemodynamic effects reduce coronary heart disease mortality in patients with hypertension compared to standard therapy?
Newer antihypertensive agents may offer metabolic and hemodynamic benefits that could reduce coronary heart disease mortality beyond simple blood pressure control, though randomized trial data is currently lacking.
Somberg et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: